A growing number of studies demonstrated that chemokines and their receptors levels were elevated in NAFLD subjects and acted indispensable roles in mediating IR, inflammation, hepatic steatosis and fibrosis, especially chemokine ligand 2 (CCL2), CCL5, and CCL20 (60, 69). This evidence concerns the gene CCL2 and fatty liver disease.